Parallel Advisors, LLC 2seventy Bio, Inc. Transaction History

Parallel Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	SELL	$3.14 - $11.2 $94 - $336	-30 Reduced 90.91%	3 $0
Q3 2023 Nov 13, 2023	SELL	$3.14 - $11.2 $94 - $336	-30 Reduced 90.91%	3 $0
Q2 2023 May 20, 2024	BUY	$8.45 - $12.48 $253 - $374	30 Added 1000.0%	33 $0
Q2 2023 Aug 04, 2023	BUY	$8.45 - $12.48 $253 - $374	30 Added 1000.0%	33 $0
Q1 2023 May 20, 2024	BUY	$9.21 - $14.98 $27 - $44	3 New	3 $0
Q2 2022 Aug 01, 2022	SELL	$10.55 - $18.81 $116 - $206	-11 Reduced 78.57%	3 $0
Q1 2022 Apr 28, 2022	BUY	$11.67 - $26.72 $163 - $374	14 New	14 $0

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $115M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.